Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/39103


Chiral Technologies: Commercial Opportunities of Today and the Future


Description: The market value for chiral platform technologies will be $2.7 billion by 2007 - an average annual growth rate of 10.8%. The niche field of chiral technologies is responsible for exciting new breakthroughs that have hugely impacted the routes to discovery and the means of production of pharmaceuticals and other chemical compounds, such as agrochemicals and flavor/fragrance compounds. Improved therapeutic activity, a reduced amount of side effects, and the requirements of regulatory groups points to the vast majority of new pharmaceutical products being 'chiral'. Other factors serving to drive the growth of the chiral technologies industry are the consolidation and outsourcing practices within companies and the "biotech revolution." This report expects to see considerable growth in the use of chiral products-particularly in the sales of chiral drugs in the areas of oncology, respiratory, and central nervous system. We also expect substantial growth in certain agrochemical applications, and in flavor and fragrance compounds. This Chiral Technologies Market Analysis Report provides a thorough review of this promising industry. This Report will help you: Discover the commercial viability of chiral technology platforms through a detailed breakdown of their widespread uses and applications Identify future growth areas for chiral intermediates with a complete breakdown of the market and a quantification of their end-uses Pinpoint the full market potential of chiral end-products- including pharmaceuticals, agrochemicals, and fragrance and flavor chemicals-through a comprehensive analysis of the market statistics, therapeutic areas, chemical structures, and identification of "hot" areas for currently marketed products and future products already in the pipeline Gain a thorough understanding of today's market via a discussion and instructive case studies of the various business models, strategies, and issues which impinge on the chiral technologies industry Focus on potential lucrative ventures from an identification of market segments that have yet to be fully exploited and which present significant commercial opportunities Look inside more than 45 companies working within the chirals industry, including their product pipelines, alliances, business strategies, and more


Contents: Executive Summary

Introduction

Overview of Chirality

History and Importance of Chiral Technologies

Chiral Technologies Description
Chiral Pool & Derivatives
Racemate Separation Techniques-Resolution.
Preferential Crystallization
Diastereomer Crystallization
Kinetic Resolution
Miscellaneous Separation Techniques
Asymmetric Synthesis
Biocatalysis
Chemocatalysis
Phase Transfer Catalysis
Chiral Auxiliaries
Analysis
Polarimetry
High Pressure Liquid Chromatography
Simulated Moving Bed
Gas Liquid Chromatography
Nuclear Magnetic Resonance Spectroscopy
X-ray Crystallography
Circular Dichroism
Recent Developments
Chiral Pool
Racemate Separation
Asymmetric Synthesis
Other Recent Developments

Chiral Technologies Industry Development
Background
Chiral Technologies Industry Overview
Terminology
Industry Participants
Chiral Platform Technology Suppliers
Chiral Intermediate Suppliers
Chiral End-Product Suppliers
Academic Practitioners of Chiral Technology
Historical Development of Chiral Technologies Industry
Market Drivers
Regulatory Issues
Outsourcing & Consolidation
Pharmaceutical Lifecycle Management and the "Racemic Switch"
Healthcare Reforms
Self-Perpetuation Process
Biotechnology Revolution
Journals, Conferences, Trade Literature, & Web Sites

Chiral End-Products, Intermediates, & Platform
Technologies: Market Statistics & Forecasts
Overview
Pharmaceuticals
Overview
Therapeutic Areas
Pipeline Drugs
Agrochemicals
Organophosphorus Compounds
Pyrethroids
Propionic Acid-Derived Herbicides
Acylanilides and Triazole Related Fungicides
Insect hormones and Pheromones
Flavor/Fragrance Compounds
Terpenoids
Ionones, Damascones & Related Compounds
Acyclic Alcohols, Esters, Acids and Aldehydes
Lactones
Woody Odorants
Musk Odorants
Miscellaneous
Chiral Platform Technologies
Others

Regulatory & Environmental Issues
The Pathway to Drug Approval
Specific FDA policy on Stereoisomeric Drugs
Policy Statement for the Development of New Stereoisomeric Drugs, 1992
FDA Regulation 21 CFR 314.108
Policy on Period of Marketing Exclusivity for Newly Approved Drug Products with Enantiomer Active Ingredients;
Request for Comments [Federal Register, Vol. 62, p.2167]
BACPAC I: Intermediates in Drug Substance Synthesis
Rest of the World
Environmental Regulations

Strategic Issues
Business Models
Patenting
Licensing
Examples of Deal Structures in the Chiral Technologies Industry

Company Profiles

Glossary of Technical Terms and Abbreviations




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/39103

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 08/09/2008 00:36:35
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Chiral Technologies: Commercial Opportunities of Today and the Future

Web Address:
http://www.researchandmarkets.com/reports/39103

Office Code:
OCHHIIQPTQY

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic €5,297.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 08/09/2008 00:36:35


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World